Published by Coherent Market Insights
Posted on September 22, 2021
4 min readLast updated: February 3, 2026
The Advanced Glycation End Products market is projected to grow due to rising neurodegenerative disorders, with a CAGR of 5.4% from 2021 to 2028.
According to the report, the global advanced glycation end products market was valued at US$ 1.56 Bn in 2020. It is projected to expand at a CAGR of 5.4% from 2021 to 2028. Advanced glycation end products (AGEs) are a group of compounds that are usually developed via non-enzymatic reactions that occur between the carbonyl groups of reducing sugars & the free lipids, amino groups of proteins, or nucleic acids.
The Global Advanced Glycation End Products Market report provides a comprehensive analysis of key market trends in the global Advanced Glycation End Products market. It also includes a discussion of historical trends, current market conditions, competitive landscape, growth opportunities, and fact-based challenges. The report quantifies the market share held by major players in the industry and provides an in-depth view of the competitive landscape. In terms of revenue (US$) and production, the market size is calculated during the study period along with details about the factors (drivers and constraints) influencing the market growth.
Key Topics Covered in this Advanced Glycation End Products Market Reports: Market Summary, Table of Contents, List of Figures, List of Tables, Report Structure, Segmentation
To understand how our report can bring a difference to your business strategy request a sample report: https://www.stratagemmarketinsights.com/sample/42393
Competition analysis
Global Advanced Glycation End Products market players are defending and expanding their respective market share with a focus on mergers and acquisitions, joint ventures, and strategic partnerships. Some of the key players profiled in the study are:
AbbVie, Inc. (Allergan Plc), Merck KGaA, Takeda Pharmaceutical Company Limited, Estée Lauder Companies, Shiseido Company, Limited, Beiersdorf AG, L’Oreal S.A., NuFACE, Rodan & Fields, PhotoMedex, Inc., Ostium Cosmetics, Cell Biolabs, Inc., Shanghai Korain Biotech Co., Ltd.
Segments Covered in the Report
By Product Type, the market is primarily segmented into:
Non-fluorescent AGEs, Fluorescent AGEs
By Applications, the market is segmented into:
Diabetic Complications, Cancer, Bone Diseases, Neurodegenerative Diseases, Others
The key player information is as follows:
This report surveys the global Advanced Glycation End Products market and analyzes and surveys development status and forecasts in five different regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Key Benefits For Stakeholders
The Market Intelligence Platform helps you understand:
Benefits of Purchasing Advanced Glycation End Products Market Report:
Buy Now with Discount for Premium Report: https://www.stratagemmarketinsights.com/cart/42393
Contact Us:
Mr. Shah
Stratagem Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@stratagemmarketinsights.com
Published By MN
The post Advanced Glycation End Products Market: Rising incidences of neurodegenerative disorders to drive the market appeared first on Gatorledger.
The article discusses the growth of the Advanced Glycation End Products market, driven by neurodegenerative disorders.
What are the key players in the AGEs market? Companies like AbbVie, Merck, and Takeda are major players.
What is the projected growth rate for the AGEs market? The market is expected to grow at a CAGR of 5.4% from 2021 to 2028.
Explore more articles in the Research Reports category
